Physician profile
He Li
NPI 1023542495
$1,927.67
in general payments reported to CMS, 2019-2025
10 companies · $568 in 2025
The $568 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.17 · 2022: $12.67 · 2023: $662 · 2024: $660 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,889.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,016.26 | 2023-2025 | |
| Alcon Vision LLC | $311.88 | 2024 | Clareon, Hydrus Microstent, Rocklatan |
| Ocular Therapeutix, INC. | $140.66 | 2021-2025 | Dextenza |
| Glaukos Corporation | $124.68 | 2023 | |
| Apellis Pharmaceuticals, INC. | $121.67 | 2025 | Syfovre |
| Rxsight INC | $69.81 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Alimera Sciences, INC. | $55.22 | 2023-2024 | Iluvien, Yutiq |
| Astellas Pharma US INC | $34.77 | 2025 | Cresemba |
| New World Medical,INC. | $33.45 | 2022-2023 | |
| Amgen INC. | $19.27 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw He Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.